Products from SYNkinase
SYNkinase, headquartered in Australia, is a primary producer of research-use-only biomedical reagents, which it markets to life-science and drug-discovery researchers affiliated with universities, research institutes and industry. SYNkinase was established in 2008 by Professor Andrew Wilks and Dr. Xian Bu. The founders of the company have been involved in pharmaceutical drug discovery for three decades and have extensive scientific, company and board experience.
More information at: www.adipogen.com/synkinase
No results were found for the filter!
(+)-JQ1
Item number: SYN-3004-M001
Soluble in DMSO or ethanol. (+)-JQ1 is a potent, high affinity, selective BET bromodomain inhibitor (IC(50) values of 17.7, 32.6, 76.9 and 12942nM respectively for BRD2 (N-terminal (N)), BRD4 (C-terminal (C)), BRD4 (N) and CREBBP, respectively. Target: BET bromodomain
| Application: | BET bromodomain inhibitor |
| CAS | 1268524-70-4 |
| MW: | 457 D |
From 165.00€
*
NEW
PLX-4032
Item number: SYN-1161-M001
Soluble in DMSO or ethanol. PLX4032 (Vemurafenib, RG7204, Zelboraf, RO5185426) is a novel and potent inhibitor of B-RafV600E with an IC(50) of 31nM. Target: Raf , Kinase Group: TKL , Substrate: Serine-Threonine
| Keywords: | Vemurafenib, RG7204, Zelboraf, RO5185426 |
| Application: | B-Raf V600E inhibitor |
| CAS | 918504-65-1 |
| MW: | 489,9 D |
From 66.00€
*